MEDI6012
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for MEDI6012, covering 2018-03-19 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism [Phase 2]